ReviewParasites & vectors2025
Plasmodium cynomolgi: potential emergence of new zoonotic malaria in Southeast Asia.
Review in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Malaria Epidemiology andTropical medicine and infectious disease · 2026Article
- Accurate and sensitive TaqMan real-time PCR assays to detect and quantify simian malaria parasites Plasmodium cynomolgi, Plasmodium inui and Plasmodium coatneyi.Malaria journal · 2026Article
- Zoonotic malaria in Southeast Asia's changing landscapes: vector complexity, challenges, and future strategies.Parasites & vectors · 2026Review
- Comparative serum proteomics of plasmodium-infected free-living macaques in Thailand: Host immune responses and candidate biomarkers for zoonotic malaria.Veterinary world · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The reported cases of Plasmodium cynomolgi in Southeast Asia pose a significant public health concern. Sporadic reports of human Plasmodium cynomolgi infections have increased in the past few years, raising attention regarding its potential impact on human populations. Further compounding this issue are the morphological similarities between P. cynomolgi and the human malaria parasite Plasmodium vivax, which may lead to misdiagnosis and underreporting of P. cynomolgi infections. Both in vitro and in vivo studies have shown that P. cynomolgi can effectively invade human reticulocytes using mechanisms like those employed by P. vivax, underscoring its capacity to infect human hosts if given the opportunity. These studies collectively highlight the parasite's potential to establish infections in humans and emphasize the need for molecular diagnostic tools to accurately detect P. cynomolgi. Additionally, challenges in accurate diagnosis and surveillance systems may underestimate the true extent of their impact, making it imperative for healthcare authorities to bolster monitoring efforts and deploy targeted interventions. Strengthening surveillance, improving diagnostic capabilities, and developing targeted vector control strategies are crucial to mitigating the risk of P. cynomolgi becoming a major zoonotic disease like its counterpart, Plasmodium knowlesi. Thus, this review aims to highlight the current understanding of P. cynomolgi infections in human, vector, and macaque hosts based on collated data from previous studies while underscoring the urgent need for enhanced surveillance, accurate diagnostic tools, and effective vector control strategies to mitigate its potential as a significant zoonotic threat in Southeast Asia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.